Skip to content
drillr.ai
Sign up

RMD

RESMED INC

NYSE · Healthcare · Medical - Instruments & Supplies · US

$239.77
+0.33%
Ask drillr

  • Oct 19, 2026, 21:45 UTC

    The U.S. Court of Appeals for the Federal Circuit affirmed dismissal of Craig L. Linden’s patent infringement lawsuit against ResMed entities, finding the asserted claims ineligible under Section 101.

    Source:

  • Oct 19, 2026, 12:00 UTC

    RESMED INC announced the U.S. launch of its AirTouch F40 full-face fabric CPAP mask.

    Source:

  • Oct 1, 2026, 20:05 UTC

    Resmed announced it will release its first quarter fiscal 2027 financial and operational results on October 29, 2026, after the New York Stock Exchange closes.

    Source:

  • Sep 22, 2026, 19:00 UTC

    MAHA Center, a nonprofit tied to HHS Secretary Robert F. Kennedy Jr., solicited corporate sponsorship payments of up to $300,000 for the Sept. 29 MAHA Summit in exchange for access to top U.S. health officials including Kennedy and CMS head Mehmet Oz.

    Source:

  • Sep 10, 2026, 11:00 UTC

    Resmed director, chairman and CEO Michael J. Farrell sold 4,991 shares for $1,110,191 on September 8, 2026, according to a Form 4 filed with the SEC.

    Source:

  • Aug 17, 2026, 20:10 UTC

    Resmed announced that Carol Burt will become Lead Director on November 15, 2026, succeeding Ron Taylor, who will retire after the 2026 Annual Meeting of Stockholders on November 18, 2026.

    Source:

  • Aug 7, 2026, 16:01 UTC

    ResMed shares fell about 6% in morning trading on Friday after the company issued a weak fiscal 2027 revenue forecast.

    Source:

  • Aug 6, 2026, 21:58 UTC

    ResMed reported Q2 CY2026 revenue of $1.46 billion, up 8.6% year on year, in line with analyst estimates, and adjusted EPS of $2.95, beating consensus by 2%.

    Source:

  • Aug 6, 2026, 20:21 UTC

    ResMed's board of directors declared a quarterly cash dividend of US$0.66 per share, a 10% increase over the previous dividend, with a record date of August 20, 2026, and payable on September 24, 2026.

  • Jul 10, 2026, 17:56 UTC

    Resmed divests its MatrixCare business to an unnamed buyer to sharpen focus on connected care.

    Source:

  • Jul 7, 2026, 20:30 UTC

    Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners.

    Source:

  • Jun 1, 2026, 20:05 UTC

    Resmed completed the acquisition of Noctrix Health, adding Nidra Tonic Motor Activation Therapy to its sleep health portfolio.

    Source: